STENT THROMBOSIS FOLLOWING IMPLANTATION OF ENDEAVOR ZOTAROLIMUS-ELUTING STENTS IN PATIENTS WITH COMPLEX CORONARY LESIONS – INSIGHTS FROM THE LARGE, PROSPECTIVE, RANDOMIZED, MULTICENTER OPTIMIZE TRIAL

Stent thrombosis (ST) is an infrequent event following 2nd generation drug-eluting stents (DES); however, its occurrence may be catastrophic. Our objective was to report the incidence of ST in a large population treated with Endeavor zotarolimus-eluting stents (E-ZES) and randomized to short- (3